Save the date for our 2-day international conference on the 4-5th of October in Copenhagen, Denmark. This conference will address biological and clinical evaluations from a risk perspective through a mixture of presentations from standard developers, notified bodies, test houses and device manufacturers. They will present case studies with hands on experience on how to […]
Let us introduce our newest colleagues: Linda Hansson, Tatiana Mattsson and Susanne Grimsby! They are joining forces with us to help continue doing what we love to do: make complex things easier – all the way from idea to market. LINDA HANSSON, Consultant Clinical Development What will be your role at Key2Compliance? I will be part […]
Key2Compliance are happy to celebrate that our client, Atrogi, has announced first patient treated with its ATR-258 ß2-adrenoceptor agonist in their ongoing phase 1 study for the treatment of Type 2 Diabetes. Atrogi is an early-stage Swedish pharma company developing a novel solution for the treatment of Type 2 Diabetes. The trial is expected to be […]
Key2Compliance are excited to announce our move to GoCo House’s Office Hub in Gothenburg, Sweden. We moved into the Office Hub on February 1st 2023 and see GoCo as a strategic location for our continued expansion, offering opportunities to collaborate with partners and customers in an inspiring work environment. GoCo House’s Office Hub is a […]
Vill du känna dig säkrare i din roll inom Regulatory Affairs? Tillsammans med Swedish Medtech erbjuder vi nu en unik möjlighet med kompetensutveckling för dig som är ny i din roll! Under kursen får du kunskaper om Regulatory Affairs i de olika stegen från produktidé till färdig produkt och eftermarknadskrav. Föreläsare är Åse Ek och Anna […]
